Identification of early markers of Alzheimer’s disease provides opportunities for preventative treatments.
The failure of multiple Alzheimer’s disease (AD) clinical trials highlights the need for early markers that accurately identify individuals at risk during the pre-clinical stage before they develop severe symptoms. Within the last decade, spatial navigation deficits have recently emerged as one of the most sensitive behavioral markers of early AD – patients are frequently […]